The AI revolution in pharma has reached an inflection point—what was once experimental is now the strategic imperative for survival and growth. In this episode, we explore how forward-thinking executives are harnessing AI to redefine drug discovery, manufacturing, and supply chains while navigating regulatory complexity and organizational transformation.
Key Discussion Points:
With the AI-driven drug discovery market exploding from $1.5B to $15.5B by 2032, leaders who delay risk irrelevance—while those who act gain first-mover advantage in precision medicine and patient-centric care.
Who Should Listen?
C-suite executives, digital transformation leaders, and manufacturing heads preparing for AI-at-scale. Whether you’re assessing organizational readiness or prioritizing high-ROI use cases, this episode delivers a clear roadmap to lead—not follow—the AI revolution.
Tune in to future-proof your organization and turn AI potential into measurable impact!
Resources:
Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB
Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/
Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0
Website: https://respa.com
and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma!
#Pharma40 #DigitalSupplyChain #AIinPharma #IoT #Robotics #DigitalTransformation #SupplyChainInnovation #Podcast #ArtificialIntelligence #AI #PharmaceuticalIndustry #Innovation #Pharma